Details of the Drug
General Information of Drug (ID: DM0TUKZ)
Drug Name |
(1-phenylcyclopentyl)methanamine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
(1-Phenylcyclopentyl)methanamine; 17511-89-6; 1-Phenylcyclopentanemethylamine; 1-(1-PHENYLCYCLOPENTYL)METHANAMINE; (1-phenylcyclopentyl)methylamine; 1-(1-phenylcyclopentyl)methylamine; 1-METHYLAMINE-1-BENZYL-CYCLOPENTANE; 1-Phenylcyclopentanemethanamine; C-(1-Phenyl-cyclopentyl)-methylamine; Cyclopentanemethylamine, 1-phenyl-; BRN 2936636; Cyclopentanemethanamine,1-phenyl-; CHEMBL382127; CHEBI:39505; Cyclopentanemethanamine, 1-phenyl-; (phenylcyclopentyl)methylamine; (1-Phenylcyclopentyl)methylamine hydrochloride; 2bua
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 175.27 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||